Mettler-Toledo International Inc. | Large-cap | Healthcare

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 3.9B
Gross Profit 2.3B 60.06%
Operating Income 1.1B 29.11%
Net Income 863.1M 22.29%

Balance Sheet Metrics

Total Assets 3.2B
Total Liabilities 3.4B
Shareholders Equity -126.9M

Cash Flow Metrics

Operating Cash Flow 960.3M
Free Cash Flow 864.4M

Revenue & Profitability Trend

Mettler-Toledo Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue3.9B3.8B3.9B3.7B3.1B
Cost of Goods Sold1.5B1.5B1.6B1.5B1.3B
Gross Profit2.3B2.2B2.3B2.2B1.8B
Operating Expenses1.1B1.1B1.1B1.1B960.3M
Operating Income1.1B1.1B1.1B994.7M784.0M
Pre-tax Income1.0B973.7M1.1B949.4M748.7M
Income Tax174.1M185.0M198.1M180.4M146.0M
Net Income863.1M788.8M872.5M769.0M602.7M
EPS (Diluted)-$35.90$38.41$32.78$24.91

Income Statement Trend

Mettler-Toledo Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets1.2B1.2B1.4B1.3B1.1B
Non-Current Assets2.0B2.1B2.1B2.1B1.8B
Total Assets3.2B3.4B3.5B3.3B2.8B
Liabilities
Current Liabilities1.2B1.2B1.1B1.1B840.3M
Non-Current Liabilities2.2B2.3B2.3B2.0B1.7B
Total Liabilities3.4B3.5B3.5B3.2B2.5B
Equity
Total Shareholders Equity-126.9M-149.9M24.8M171.4M282.7M

Balance Sheet Composition

Mettler-Toledo Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income863.1M788.8M872.5M769.0M602.7M
Operating Cash Flow960.3M1.0B874.8M808.2M674.1M
Investing Activities
Capital Expenditures-102.3M-104.5M-120.8M-103.9M-89.4M
Investing Cash Flow-119.5M-131.7M-139.4M-314.1M-100.4M
Financing Activities
Dividends Paid-----
Financing Cash Flow-879.7M-878.8M-2.7B-2.6B-770.6M
Free Cash Flow864.4M860.6M737.8M801.2M632.2M

Cash Flow Trend

Mettler-Toledo Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 28.82
Forward P/E 27.09
Price to Book -135.91
Price to Sales 6.26
PEG Ratio 27.09

Profitability Ratios

Profit Margin 22.17%
Operating Margin 25.19%
Return on Equity -680.23%
Return on Assets 21.22%

Financial Health

Current Ratio 1.01
Debt to Equity -11.40
Beta 1.39

Per Share Data

EPS (TTM) $40.04
Book Value per Share -$8.76
Revenue per Share $181.70

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
mtd24.0B28.82-135.91-680.23%22.17%-11.40
Thermo Fisher 152.5B23.693.0913.70%15.19%69.23
Danaher 140.5B37.982.767.22%15.81%34.56
Idexx Laboratories 42.1B48.3329.2159.33%22.76%73.16
Agilent Technologies 33.0B28.605.3718.88%17.59%60.04
Iqvia Holdings 27.4B21.644.6121.64%8.61%242.91

Financial data is updated regularly. All figures are in the company's reporting currency.